Eckert & Ziegler Strahlen- und Medizintechnik AG provided earnings guidance for the year 2022. For the current fiscal year 2022, the board expects an increase in sales to around EUR 200 million and a net income of around EUR 38 million. The forecast is based on a weighted average exchange rate of USD 1.20 per EUR and is subject to the assumption that no major disruptions continue to result from the developments in Ukraine.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.78 EUR | -0.78% | -1.76% | +10.85% |
15/05 | ECKERT & ZIEGLER : Hauck & Aufhauser reiterates its Buy rating | ZD |
14/05 | Eckert & Ziegler SE Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+10.85% | 104.22Cr | |
+8.57% | 806.22Cr | |
-3.79% | 469.51Cr | |
-4.85% | 298.24Cr | |
+10.00% | 214.26Cr | |
-30.46% | 108.71Cr | |
+3.98% | 90Cr | |
-24.86% | 76Cr | |
-52.26% | 73Cr | |
-25.49% | 69Cr |
- Stock Market
- Equities
- EUZ Stock
- News Eckert & Ziegler SE
- Eckert & Ziegler Strahlen- und Medizintechnik AG Provides Earnings Guidance for the Year 2022